These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29407053)

  • 1. Antiplatelet Therapy in Diabetes.
    Majithia A; Bhatt DL
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):223-235. PubMed ID: 29407053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.
    Colwell JA
    Am J Cardiovasc Drugs; 2004; 4(2):87-106. PubMed ID: 15049721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.
    Capranzano P; Capodanno D
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):307-17. PubMed ID: 23469911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin resistance: current concepts.
    Mason PJ; Freedman JE; Jacobs AK
    Rev Cardiovasc Med; 2004; 5(3):156-63. PubMed ID: 15346099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
    Sirois C; Poirier P; Moisan J; Grégoire JP
    Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.
    Mathewkutty S; McGuire DK
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin resistance: biological and clinical implications.
    Tseeng S; Arora R
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):5-12. PubMed ID: 18287586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromes.
    Ferreiro JL; Cequier AR; Angiolillo DJ
    Trends Cardiovasc Med; 2010 Oct; 20(7):211-7. PubMed ID: 22293020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases.
    Jourdi G; Lordkipanidzé M; Philippe A; Bachelot-Loza C; Gaussem P
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Antiplatelet Therapy in Primary Prevention. A Review.
    Ostergaard L; Fosbol EL; Roe MT
    Curr Pharm Des; 2017; 23(9):1294-1306. PubMed ID: 27917712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The concept of aspirin "resistance": mechanisms and clinical relevance].
    Reny JL; Bonvini RF; Barazer I; Berdagué P; de Moerloose P; Schved JF; Gris JC; Fontana P
    Rev Med Interne; 2009 Dec; 30(12):1020-9. PubMed ID: 19595490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of platelet adhesion by antiplatelet drugs helps prevent cardiovascular complications of diabetes mellitus.
    Zingg W; Leibel BS
    Med Hypotheses; 1985 Oct; 18(2):119-27. PubMed ID: 3916696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Anthocyanin to Prevent Cardiovascular Disease in Diabetes.
    Gaiz AA; Mosawy S; Colson N; Singh I
    Altern Ther Health Med; 2018 May; 24(3):40-47. PubMed ID: 29477135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and Altered Aspirin Pharmacology.
    Norgard NB
    Clin Pharmacokinet; 2018 Jun; 57(6):663-672. PubMed ID: 29139042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
    Franchi F; Rollini F; Aggarwal N; Hu J; Kureti M; Durairaj A; Duarte VE; Cho JR; Been L; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2016 Sep; 134(11):780-92. PubMed ID: 27559041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.
    Ferreiro JL; Cequier ÁR; Angiolillo DJ
    Diab Vasc Dis Res; 2010 Oct; 7(4):274-88. PubMed ID: 20921091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy.
    Singla A; Antonino MJ; Bliden KP; Tantry US; Gurbel PA
    Am Heart J; 2009 Nov; 158(5):784.e1-6. PubMed ID: 19853698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.